419 related articles for article (PubMed ID: 18466349)
21. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
[TBL] [Abstract][Full Text] [Related]
22. Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function.
Ferraz-Amaro I; González-Gay MA; Diaz-González F
J Rheumatol; 2014 Apr; 41(4):658-65. PubMed ID: 24532832
[TBL] [Abstract][Full Text] [Related]
23. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome.
Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T
Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725
[TBL] [Abstract][Full Text] [Related]
24. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann PH; Karagiannis E; Wilhelm B; Forst T
Horm Metab Res; 2009 Mar; 41(3):202-6. PubMed ID: 19224430
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.
Yagmur E; Weiskirchen R; Gressner AM; Trautwein C; Tacke F
Diabetes Care; 2007 May; 30(5):1168-72. PubMed ID: 17337499
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects.
Shin JY; Chang SJ; Shin YG; Seo KS; Chung CH
Diabetes Res Clin Pract; 2009 May; 84(2):152-7. PubMed ID: 19264371
[TBL] [Abstract][Full Text] [Related]
27. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children.
Friebe D; Neef M; Erbs S; Dittrich K; Kratzsch J; Kovacs P; Blüher M; Kiess W; Körner A
Int J Pediatr Obes; 2011 Jun; 6(2-2):e345-52. PubMed ID: 20950077
[TBL] [Abstract][Full Text] [Related]
28. Retinol-binding protein-4 in experimental and clinical metabolic disease.
von Eynatten M; Humpert PM
Expert Rev Mol Diagn; 2008 May; 8(3):289-99. PubMed ID: 18598108
[TBL] [Abstract][Full Text] [Related]
29. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
30. Elevated retinol binding protein 4 contributes to insulin resistance in spontaneously hypertensive rats.
Ou HY; Wu HT; Yang YC; Wu JS; Cheng JT; Chang CJ
Horm Metab Res; 2011 May; 43(5):312-8. PubMed ID: 21365528
[TBL] [Abstract][Full Text] [Related]
31. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.
Cabré A; Lázaro I; Girona J; Manzanares J; Marimón F; Plana N; Heras M; Masana L
J Intern Med; 2007 Oct; 262(4):496-503. PubMed ID: 17875187
[TBL] [Abstract][Full Text] [Related]
32. Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus.
Chen CC; Wu JY; Chang CT; Tsai FJ; Wang TY; Liu YM; Tsui HC; Chen RH; Chiou SC
Metabolism; 2009 Dec; 58(12):1812-6. PubMed ID: 19709697
[TBL] [Abstract][Full Text] [Related]
33. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.
Gavi S; Stuart LM; Kelly P; Melendez MM; Mynarcik DC; Gelato MC; McNurlan MA
J Clin Endocrinol Metab; 2007 May; 92(5):1886-90. PubMed ID: 17299074
[TBL] [Abstract][Full Text] [Related]
34. Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study.
Lewis JG; Shand BI; Frampton CM; Elder PA; Scott RS
Clin Biochem; 2008 Sep; 41(13):1034-8. PubMed ID: 18588869
[TBL] [Abstract][Full Text] [Related]
35. Retinol-binding protein 4 in human obesity.
Janke J; Engeli S; Boschmann M; Adams F; Böhnke J; Luft FC; Sharma AM; Jordan J
Diabetes; 2006 Oct; 55(10):2805-10. PubMed ID: 17003346
[TBL] [Abstract][Full Text] [Related]
36. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
[TBL] [Abstract][Full Text] [Related]
37. Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women.
Usui S; Ichimura M; Ikeda S; Okamoto M
Clin Chim Acta; 2009 Jan; 399(1-2):45-8. PubMed ID: 18782570
[TBL] [Abstract][Full Text] [Related]
38. Effect of liver fat on insulin clearance.
Kotronen A; Vehkavaara S; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
[TBL] [Abstract][Full Text] [Related]
39. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass.
Frige' F; Laneri M; Veronelli A; Folli F; Paganelli M; Vedani P; Marchi M; Noe' D; Ventura P; Opocher E; Pontiroli AE
Nutr Metab Cardiovasc Dis; 2009 Mar; 19(3):198-204. PubMed ID: 18684601
[TBL] [Abstract][Full Text] [Related]
40. Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.
Lalić NM; Marić J; Svetel M; Jotić A; Stefanova E; Lalić K; Dragasević N; Milicić T; Lukić L; Kostić VS
Arch Neurol; 2008 Apr; 65(4):476-80. PubMed ID: 18413469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
